AMVAC Acquires Orthene From Valent

Matt Hopkins Posted by Matt Hopkins|8 January 2008

AMVAC Chemical Corp. has acquired the Orthene (acephate) line of products from Valent U.S.A. Corp., according to the Valent web site. Terms of the transaction, which expected to close in mid-January, were not disclosed.

Valent noted that the deal would allow the company to focus on its current portfolio of crop protection products as well as what company officials consider the healthiest pipeline of new materials in the Valent’s 19-year history.

Advertisement

Trevor Thorley, president and chief operating officer of Valent said, “After a highly successful history with Orthene, it is appropriate for us to direct our efforts towards our growing portfolio of innovative new products and to pass this fine product to a well-established firm that is capable of continuing that winning tradition.”

Eric Wintemute, president and chief executive officer of American Vanguard (AMVAC) noted several reasons that the Orthene acquisition would be helpful for AMVAC. “Our expertise in organophosphate chemistry manufacturing and marketing will permit a seamless assimilation of this product line into our existing operations. Our considerable sales presence in the U.S. cotton market, our continuing growth in the vegetable segment, and our recent focus on turf and ornamental applications all represent key market opportunities for the expansion of the Orthene brand.”

Under the agreement, AMVAC will take ownership of the assets of the Orthene product line including all registrations, formulations, and existing inventories of the agricultural and professional product lines, which include:

Top Articles
India Government Extends Interim Approval for Drone-Based Pesticide Application
  • Orthene 75 S Insecticide
  • Orthene 75 S WSP Insecticide
  • Orthene 90 S Insecticide
  • Orthene 97 Insecticide
  • Orthene PCO Pellets Insecticide
  • Orthene Turf, Tree & Ornamental Spray Insecticide
  • Orthene Turf, Tree & Ornamental Spray 97 Insecticide

The transfer of ownership will include proprietary formulation information, registration rights, marketing materials, certain intellectual property rights, and existing inventories of Orthene, according to the web site.

Hide picture